Skip to main content
Clinical Trials/NCT02196116
NCT02196116
Unknown
Not Applicable

Amyloïd Load in Elderly Population: Effect of Cognitive Reserve

University Hospital, Bordeaux1 site in 1 country120 target enrollmentJuly 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Plaque, Amyloid
Sponsor
University Hospital, Bordeaux
Enrollment
120
Locations
1
Primary Endpoint
Amyloid load
Last Updated
11 years ago

Overview

Brief Summary

This research aim to explore relationships between the presence of amyloid burden and cognitive performance, and its modulation by educational level. For this purpose we will combine Positron emission tomography (PET) imaging and neuropsychological assessment acquired on 3 groups of subjects, from two population-based cohorts "3C" and "AMIMage" The first group includes cognitively intact participants who will serve as controls, the second group, subjects with mild cognitive impairments without memory complaint and the third, subjects with both mild cognitive impairments and memory complaint.

Detailed Description

Influence of educational level on the relationship between disease-specific lesion development and cognitive function will be assessed, as measured by amyloid PET imaging and a battery of neuropsychological tests at the very early stages of the disease, comparatively to age-matched controls. In addition, this project will explore the influence of cognitive complaint. It's assumed that 1) the amyloid-PET measures in age-matched controls and subjects from the two cohorts will correlate with cognitive performances; 2) the amyloid burden will be higher in high- than in low-educated subjects with similar cognitive impairment; and 3) similarly the amyloid burden will be higher in subjects with cognitive complaint compared to subjects without cognitive complaint. Considering a longer term, the clinical follow-up of study participants will allow to investigate the prognosis value of amyloid load for improving the prediction of cognitive decline and disease progression.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
July 2016
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participation in the AMI or 3C cohorts Group 1- Controls
  • MMSE \> 24 or \> 26 for low and high levels of education, respectively.
  • Without memory impairment (for episodic memory) on the Free and Cued Selective Reminding Test RL/RI-16 items (FCSRT), free recall \> 22 and total recall \>42, according to the thresholds for population-based studies
  • Without memory complaint
  • Without dementia Group 2- Cognitively-impaired subjects without dementia and without memory complaints
  • Mini Mental State Evaluation (MMSE) \< 24 or \< 26 for low and high levels of education, respectively
  • With memory impairments according to the RL/RI-16 test (free recall≤22 and/or total recall ≤42), according to the thresholds for population-based studies defined by Auriacombe et al.,
  • Without memory complaint
  • Without dementia Group 3- Cognitively-impaired subjects without dementia and with memory complaints
  • MMSE \< 24 or \< 26 for low and high levels of education, respectively

Exclusion Criteria

  • Being left handed
  • Presence of dementia (based on the clinical diagnosis)
  • Presence of stroke
  • Presence of Parkinson's disease
  • Presence of a counter-indication for MRI
  • Presence of a counter-indication for PET Scan with \[18F\]-Flutemetamol
  • Presence of any health problem preventing travel to the imaging service of the University Hospital
  • Being under the legal guardianship of another person or being unable to provide consent to participate
  • Pregnant or breastfeeding woman

Outcomes

Primary Outcomes

Amyloid load

Time Frame: at inclusion (day 0)

Secondary Outcomes

  • Neuropsychological scores(At inclusion (Day 0))
  • Educational level(At inclusion (Day 0))
  • Memory complaint(At inclusion (Day 0))

Study Sites (1)

Loading locations...

Similar Trials